ReviewActa neurologica Belgica2026
Beyond Wilson Disease: a comprehensive review of the Non-Wilsonian Causes and differentiating imaging features of the "Face of the Giant Panda" sign.
Review in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The "Face of the Giant Panda" sign is a characteristic magnetic resonance imaging (MRI) appearance classically associated with Wilson disease. Although traditionally considered highly suggestive of Wilson disease, increasing evidence shows that this pattern is not pathognomonic and may occur across a wide range of neurological disorders. This review provides a comprehensive account of non-Wilsonian causes of the giant panda sign, with emphasis on pathophysiological mechanisms, characteristic imaging features, and, critically, the additional MRI findings beyond the panda configuration itself that allow these mimics to be distinguished from Wilson disease and from one another. A narrative review of the literature was conducted using PubMed/MEDLINE and Google Scholar, focusing on reports describing the giant panda sign and panda-like midbrain appearances. Reported etiologies were classified into mitochondrial, toxic-metabolic, infectious, inflammatory-demyelinating, vascular, neoplastic, prion, neurodegenerative, nutritional, and hypoxic-ischemic disorders. For each entity, we summarize diffusion-weighted imaging behavior, contrast-enhancement pattern, associated lesion distribution, and key clinical differentiators in a consolidated comparison table, and we present an expanded diagnostic algorithm incorporating these clues. Panda-related variant signs (miniature panda, double panda, and "bright eyes") are also described. Important mimics include Leigh syndrome, osmotic demyelination syndrome, methanol toxicity, isoniazid toxicity, metronidazole neurotoxicity, Japanese and West Nile encephalitis, neurocysticercosis, acute disseminated encephalomyelitis, Wernicke encephalopathy, maple syrup urine disease, primary CNS lymphoma, Creutzfeldt-Jakob disease, and select vascular and space-occupying lesions. Recognition of accompanying imaging findings-diffusion restriction, enhancement, hemorrhage, calcification, and the association of basal ganglia or white matter involvement-together with clinical and biochemical correlation, is essential for accurate diagnosis. The giant panda sign should therefore be regarded as a neuroradiological pattern of selective midbrain injury rather than a disease-specific marker.
Indexed as
Identifiers
42837041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.